Edition:
United States

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

15.51USD
1:03pm EDT
Change (% chg)

$-0.48 (-3.00%)
Prev Close
$15.99
Open
$15.73
Day's High
$16.45
Day's Low
$15.51
Volume
6,273
Avg. Vol
7,639
52-wk High
$24.70
52-wk Low
$10.01

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $462.19
Shares Outstanding(Mil.): 28.90
Dividend: --
Yield (%): --

Financials

  NITE.OQ Industry Sector
P/E (TTM): -- 240.92 34.18
EPS (TTM): -1.85 -- --
ROI: -- -5.87 13.17
ROE: -- -7.71 15.15

BRIEF-Nightstar Therapeutics Starts Star Phase 3 Registrational Trial For Nsr-Rep1 In Choroideremia

* NIGHTSTAR THERAPEUTICS ANNOUNCES INITIATION OF STAR PHASE 3 REGISTRATIONAL TRIAL FOR NSR-REP1 IN CHOROIDEREMIA

Mar 05 2018

Earnings vs. Estimates